Disseminated Intravascular Coagulation in a High-Risk Pediatric Oncology Patient: A Pediatric Simulation Case for Residents and Fellows

高危儿童肿瘤患者弥散性血管内凝血:住院医师和专科医师儿科模拟病例

阅读:1

Abstract

INTRODUCTION: Disseminated intravascular coagulation (DIC) is an acquired life-threatening condition defined by systemic coagulation imbalance. Due to the high mortality associated with this condition, it is paramount that providers quickly recognize key clinical signs and laboratory value changes. METHODS: This simulation was designed for pediatric residents, fellows, or other providers who treat patients at risk for DIC. The case was a 6-year-old boy with newly diagnosed leukemia admitted to the oncology service for induction chemotherapy who presents with a nosebleed, then develops profuse, multisite bleeding consistent with a diagnosis of DIC. The goals for the team were to treat the epistaxis, verbalize DIC as the diagnosis, and address hemodynamic instability due to DIC. Directly following completion of the scenario, a debriefing session was facilitated using the PEARLS (Promoting Excellence and Reflective Learning) method. A pre- and postsimulation survey was completed that consisted of participant self-assessment of their ability to achieve each of the three educational objectives, where they rated their confidence in managing epistaxis, recognizing DIC, and achieving hemodynamic stability on a 3-point scale (1 = almost there, 2 = proficient, 3 = mastery). RESULTS: Of the 91 simulation participants, which included pediatric and pharmacy residents, 89 completed the survey. The median competency score significantly increased by 0.49 points (99% CI, 0.37 to 0.61) from pre- to postsimulation (p < .001). DISCUSSION: This simulation serves as a learning tool for teaching the clinical and laboratory presentation of DIC, guiding management of epistaxis, and addressing hemodynamic instability.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。